We are Axions

Let’s Change How We Care

Axio is a deep-science medical technology company with extensive expertise in biomaterials based medical devices for pre-hospital, intra-operative and post-operative clinical needs. Our focus is on devices for management of trauma, surgical and chronic wounds.

We bring together our biomaterials expertise with the contemporary knowledge of medicine and engineering to design novel solutions for management of trauma, surgical and chronic-infectious wounds.

Our flagship product, Axiostat, is a patented, clinically validated haemostat that stops moderate to severe bleeding instantly in surgeries and in pre-hospital trauma. Axiostat is USFDA 510(k) cleared and is also European CE approved.

Play Video

In Advanced Wound Care range, Axio has launched the next-generation MaxioCel wound dressing. MaxioCel is designed to heal patients suffering from acute and chronic wounds (diabetic foot ulcers, pressure ulcers, burns, bed sores, cavity wounds and surgical site infections) by effectively managing exudates, pain reduction and scar less healing.

Axio has recently expanded its portfolio to include RESIST+ range of high-quality hygiene and protection solutions. RESIST+ range includes alcohol-based sanitizers, surface disinfectants, disinfecting wipes, and antimicrobial hand wash, manufactured under without any toxic chemicals.

All Axio products are manufactured in state-of-the-art ISO 13485 and GMP certified facility.

Axio intends to be the first choice for any customer looking for advanced wound care, hemostatic, and hygiene solutions worldwide and the company is positioned to upgrade wound care and hygiene care in both the institutional and consumer segments.

Mission

To Save, Improve and Touch lives of civilian and military victims, from uncontrolled hemorrhage by providing efficient solutions to stop bleeding through the use of innovative medical technology

Vision

To be the first choice of customers looking for advanced and affordable wound care solutions worldwide.

40+

Countries

100+

Axions

1M+

Units Shipped

40+

Countries

100+

Axions

1M+

Units Shipped

Meet Our Team

Leo Mavely

Founder & CEO

Gourav Maheshwari

Director – Finance

Dr. Kiran Sonaje

Head – R&D

Priya Shah

Head - Design

Sreeja Chandran

General Manager – HR

Yashas Chandra

General Manager - International Sales

Ragavendra Krishnan

General Manager - Digital

Leo Mavely

Founder & CEO

Gourav Maheshwari

Director – Finance

Dr. Kiran Sonaje

Head – R&D

Priya Shah

Head - Design

Sreeja Chandran

General Manager – HR

Yashas Chandra

General Manager - International Sales

Ragavendra Krishnan

General Manager - Digital

Scientific Advisory Board

Dr. Shiladitya Sengupta

Harvard Medical School, MIT

Dr. S V Mahadevan

Stanford University Medical Center

Our Investors

Bangalore

Ahmedabad

Leo Mavely

Founder & CEO

Passionate about medtech innovations for unmet healthcare needs, Leo founded Axio Biosolutions (“Axio”) in the final year of his undergraduate bioengineering degree.

Leo is a recipient of Silicon Valley Challenge Award, 2014 and Anjani Mashelkar Innovation Award, 2013 and was an invited speaker at the prestigious Indian Science Congress in 2010. He has also been featured by Fortune Magazine as one of the 40 under 40 Business Leaders from India consecutively for the years 2016 – 2019, and by Entrepreneur Magazine in 35 under 35 Game Changing Entrepreneurs (2020).

Leo holds a Bachelor’s Degree in Bioengineering from MDU, Rohtak and Advanced Diploma in Managing Tech Ventures. A national level basketball player during school, Leo continues to be an ardent sports lover.

Gourav Maheshwari

Director – Finance

Gourav leads the finance function at Axio as Director – Finance and is responsible for budgeting, financial planning, investor relations and reporting.

Gourav has finance experience across leading publicly-listed companies such as Asian Granito Limited and Jaihind Projects Limited. He started his career with the finance team of Adani Wilmar Limited where he handled a consortium of 13 banks with a borrowing amount of $750mn.

Gourav is a qualified Chartered Accountant from the Institute of Chartered Accountants of India. Outside work, Gourav is an outdoors enthusiast and enjoys traveling and cycling.

Dr. Kiran Sonaje

Head – R&D

Kiran leads Research & Development at Axio and guides scientific innovation spanning the development of product pipeline, conceptualization, prototype development and clinical evaluations. 

Kiran comes with over 10 years of international experience in the research and development of biomaterials and polymeric drug delivery systems. Kiran held positions as Senior Post-Doctoral Fellow at the University of Geneva (Switzerland) and as Consulting Research Scientist at Nanomega Medical Corporation (USA). He is a co-holder of 21 US Patents and has authored over twenty peer-reviewed research papers.

Kiran holds a Master’s Degree in Pharmaceutics and Ph.D. in Chemical Engineering from NTHU, Taiwan. Kiran is passionate about food and enjoys cooking exotic delicacies for his daughter.

Priya Shah

Head of Design

Priya leads Design at Axio and lends a creative design touch to every product innovation that is shipped at Axio. She is involved with all aspects of design required for product marketing.

Priya comes with over 10 years of experience and multiple entrepreneurial stints in product and graphic design.

Priya holds a Bachelor’s Degree in Interior Design from CEPT University. Priya is passionate about art, poetry, yoga and enjoys photography.

Sreeja Chandran

General Manager – HR

Sreeja is a General Manager-HR at Axio responsible for driving HR functions and policy implementations at Axio.

Sreeja comes with an extensive background of working with companies like Suvilas Properties, VBHC, Amazon and HSBC, and has handled a diverse portfolio spanning human resources, corporate communications and risk management and operations.

Sreeja holds an MBA from Mysore University. Sreeja is a voracious reader and is a quintessential people person, thereby finding perfect harmony between her personal and professional pursuits.

Yashas Chandra

General Manager - International Sales

Yashas is a General Manager – International Sales at Axio. He is passionate about making healthcare accessible and is responsible for expanding and scaling Axio’s business globally.

Yashas has previously launched numerous cardiac medical devices successfully and has extensive knowledge and experience navigating global regulatory requirements and compliances.

Yashas holds an MBA from Manipal Institute of Management, Manipal University. A passionate quizzer since his college days, Yashas remains active in reading and learning widely and likes to try out new cuisines.

Ragavendra Krishnan

General Manager - Digital

Ragavendra Krishnan is a General Manager-Digital at Axio responsible for generating Digital demand by driving visibility & engagement for Axiostat, Maxiocel, Sureklot & RESIST+. He is responsible for entire digital revenue growth, digital customer journey, nurturing across funnel, customer acquisition & retention.

Ragavendra is a seasoned tech-savvy Digital Marketer with 8+ years of experience in Digital transformation, demand generation & performance marketing for both B2B & B2C across verticals FMCG, Food & Beverage, Education, Entertainment & Real estate. He has worked with brands like Bharat Matrimony, Magzter, Chai Point, Smoor to set up and scale up their digital business.

He holds a PGDM (Marketing & Finance) from MSSM Business School. He is a gamer and an avid travel enthusiast.

Dr. Shiladitya Sengupta

Harvard Medical School, MIT

Dr. Shiladitya Sengupta serves as an Associate Professor of Medicine at Harvard Medical School and of Health Sciences and Technology at MIT, and he is a principal investigator at the Dana Farber Cancer Institute. He had served as the co-chair of the Center for Regenerative Medicine at the Brigham and Women’s Hospital in Boston.

He completed his Ph.D. at Trinity College, University of Cambridge, where he was a Nehru Scholar as well as a British Chevening Scholar. He is an alumnus of the All India Institute of Medical Sciences, where he received the Geeta Mittal Gold Medal.

Dr. Sengupta has been recognized with the TR35 Innovator Award, an honor given to the top 35 innovators worldwide by MIT Technology Review magazine; the Era of Hope Scholar Award and the Innovator Collaborative Award from the US Department of Defense; the Coulter Foundation Career Award; and the Shakuntala Amir Chand Award from the Indian Council for Medical Research. 

He is the co-founder of Akamara Therapeutics (previously Invictus Oncology) and Vyome Biosciences. Previously, he co-founded Mitra Biotech and Cerulean Pharma Inc., where he also served on the scientific advisory board. Dr. Sengupta has published over 100 papers, including in Nature and the Proceedings of the National Academy of Sciences, and he is an inventor on over 350 pending/granted patents.

Dr. S V Mahadevan

Stanford University Medical Center

Dr. SV Mahadevan is a Professor of Emergency Medicine at Stanford University, Palo Alto, California, and is a teaching physician at Stanford Health Care. He received his medical degree from David Geffen School of Medicine at UCLA and has been a practicing emergency medicine specialist for more than 23 years.

He was the founding chair of the Department of Emergency Medicine at Stanford (2015-17), founding director of Stanford Emergency Medicine International (2000-2015), and currently serves as both the Director of Global Affairs and Strategy for Stanford Medicine as well as the Director of South Asia Outreach, Center for Asian Health Research and Education (CARE). Dr. Mahadevan has received numerous prestigious teaching awards throughout his career and is the lead editor of the textbook, An Introduction to Clinical Emergency Medicine, which won the 2006 American Medical Writers Association Award in the Physician’s Category.

Book a Demo